geroFarma
ActiveSummary
The computed 12-month bankruptcy probability of geroFarma is 1.6% (moderate). The 2025 annual accounts show equity of €240,699 and a net result of €107,225. Equity is growing by ~66.7% per year across the filed fiscal years. Its solvency ranks better than 34% of 10485 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes · tick = 2024
Profitability81▲+10
Solvency48▲+9
Growth78=
Track record94
Bankruptcy probability, 12 months
1.6%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €15,000 at 30 days acceptable
Liquidity ample (current ratio 1.78 against 1.06 in 2024; short-term debt: 9.4% and cash: 4% of total assets), but 77.1% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
22.9%
Return on assets
10.2%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-07-2026, 20 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
20 d early
2024
20 d early
2023
14 d early
2022
7 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 4 accounts on average 15 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidy mirror How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€240,699▲ 80.3%
2024 · €133,474
Total assets
€1.1m▲ 8.1%
2024 · €974,039
Net result
€107,225▲ 98.5%
2024 · €54,029
Working capital
€77,695▲ 1,485%
2024 · €4,902
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line2022202320242025
Operating result€18,409-€42,656▲ 132%€96,119▲ 125%€173,980▲ 81.0%
Net result€12,257-€66,188▲ 440%€54,029▼ 18.4%€107,225▲ 98.5%
Equity€13,257-€79,445▲ 499%€133,474▲ 68.0%€240,699▲ 80.3%
Total assets€814,764-€963,468▲ 18.3%€974,039▲ 1.1%€1.1m▲ 8.1%
Debt€801,506-€884,023▲ 10.3%€840,565▼ 4.9%€812,469▼ 3.3%
Working capital-€122,993-€701€4,902▲ 599%€77,695▲ 1,485%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen three years in a row; 2025 is 81% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.1m
Fixed assets
€876,187 ▼ 1.0%
Current assets
€176,981 ▲ 99.4%
Equity and liabilities €1.1m
Equity
€240,699 ▲ 80.3%
Debt
€812,469 ▼ 3.3%
Debt's share of the balance-sheet total falls from 86.3% to 77.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€183,683▲
2024 · €104,734
Cash flow
€116,927▲
2024 · €62,643
Current ratio
1.78▲
2024 · 1.06
Debt to equity
3.38▼
2024 · 6.30
ROE
44.5%▲
2024 · 40.5%
ROA
10.2%▲
2024 · 5.5%
Interest coverage
9.72▲
2024 · 5.39
Debt ≤ 1 year
€99,285▲
2024 · €83,849
Debt > 1 year
€700,800▼
2024 · €751,650
Income taxes
€51,873▲
2024 · €25,614
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €788 | €0 | €8,615 | €9,702 | ▲ 12.6% |
| Other operating charges640/8 | €295 | €771 | €749 | €1,513 | ▲ 102% |
| Gross operating margin9900 | €19,492 | €43,427 | €105,483 | €185,196 | ▲ 75.6% |
| Operating profit (loss)9901 | €18,409 | €42,656 | €96,119 | €173,980 | ▲ 81.0% |
| Financial income75/76B | - | €50,000 | €2,955 | €4,006 | ▲ 35.6% |
| Recurring financial income75 | - | €50,000 | €2,955 | €4,006 | ▲ 35.6% |
| Financial charges65/66B | €49 | €11,400 | €19,431 | €18,889 | ▼ 2.8% |
| Recurring financial charges65 | €49 | €11,400 | €19,431 | €18,889 | ▼ 2.8% |
| Profit (loss) for the period before taxes9903 | €18,360 | €81,256 | €79,643 | €159,098 | ▲ 99.8% |
| Income taxes67/77 | €6,103 | €15,068 | €25,614 | €51,873 | ▲ 103% |
| Profit (loss) for the period9904 | €12,257 | €66,188 | €54,029 | €107,225 | ▲ 98.5% |
| Profit (loss) for the period to be appropriated9905 | €12,257 | €66,188 | €54,029 | €107,225 | ▲ 98.5% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €814,764 | €963,468 | €974,039 | €1.1m | ▲ 8.1% |
| Fixed assets21/28 | €790,000 | €845,588 | €885,287 | €876,187 | ▼ 1.0% |
| Tangible fixed assets22/27 | - | - | €39,449 | €30,349 | ▼ 23.1% |
| Furniture and vehicles24 | - | - | €39,449 | €30,349 | ▼ 23.1% |
| Financial fixed assets28 | €790,000 | €845,588 | €845,838 | €845,838 | = |
| Current assets29/58 | €24,764 | €117,880 | €88,752 | €176,981 | ▲ 99.4% |
| Amounts receivable within one year40/41 | - | €107,266 | €74,703 | €134,290 | ▲ 79.8% |
| Trade receivables40 | - | €7,260 | €0 | €12,929 | - |
| Other amounts receivable41 | - | €100,006 | €74,703 | €121,361 | ▲ 62.5% |
| Cash at bank and in hand54/58 | €24,710 | €10,581 | €10,969 | €42,099 | ▲ 284% |
| Deferred charges and accrued income490/1 | €54 | €33 | €3,080 | €592 | ▼ 80.8% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €814,764 | €963,468 | €974,039 | €1.1m | ▲ 8.1% |
| Equity10/15 | €13,257 | €79,445 | €133,474 | €240,699 | ▲ 80.3% |
| Contributions10/11 | €1,000 | €1,000 | €1,000 | €1,000 | = |
| Reserves13 | €12,257 | €78,445 | €132,474 | €239,699 | ▲ 80.9% |
| Distributable reserves133 | €12,257 | €78,445 | €132,474 | €239,699 | ▲ 80.9% |
| Amounts payable17/49 | €801,506 | €884,023 | €840,565 | €812,469 | ▼ 3.3% |
| Amounts payable after more than one year17 | €653,750 | €762,500 | €751,650 | €700,800 | ▼ 6.8% |
| Financial debts170/4 | €653,750 | €762,500 | €751,650 | €700,800 | ▼ 6.8% |
| Amounts payable within one year42/48 | €147,756 | €117,179 | €83,849 | €99,285 | ▲ 18.4% |
| Current portion of amounts payable after more than one year42 | €41,250 | €41,250 | €50,850 | €50,850 | = |
| Trade debts44 | €750 | €822 | €0 | - | - |
| Suppliers440/4 | €750 | €822 | €0 | - | - |
| Taxes, remuneration and social security45 | €5,756 | €15,107 | €18,023 | €48,151 | ▲ 167% |
| Taxes450/3 | €5,756 | €13,857 | €16,773 | €46,901 | ▲ 180% |
| Remuneration and social security454/9 | - | €1,250 | €1,250 | €1,250 | = |
| Other amounts payable47/48 | €100,000 | €60,000 | €14,976 | €284 | ▼ 98.1% |
| Accrued charges and deferred income492/3 | - | €4,344 | €5,066 | €12,384 | ▲ 144% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €12,257 | €66,188 | €54,029 | €107,225 | ▲ 98.5% |
| + Depreciation and write-downs630 | €788 | €0 | €8,615 | €9,702 | ▲ 12.6% |
| Operating cash flow (approximation) | €13,045 | €66,188 | €62,643 | €116,927 | ▲ 86.7% |
| Investment in fixed assets (approximation) | - | -€55,588 | -€48,314 | -€602 | ▲ 98.8% |
| Change in cash | - | -€14,129 | €389 | €31,130 | ▲ 7,904% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
11-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2022net €107,225 ▲98.5%
Operating result €173,980, net result €107,225, both a record.
31-12
Financial
Equity above €200,000Eq €240,699 ▲80.3%
4 profitable years in a row build equity to €240,699.
11-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Equity above €100,000Eq €133,474 ▲68%
3 profitable years in a row build equity to €133,474.
17-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Liquidity times 6current ratio 1.01
Current ratio from 0.17 to 1.01; short-term debt falls from €147,756 to €117,179.
24-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kortrijk · 1 establishment unit since 2021
Ground area
384 m²
Building footprint
165 m²
Volume, LiDAR
894 m³
Parcel 34016C0761/00S004, Flanders · tallest building 10.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
geroFarma
since 20212.322.378.948
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34016C0761/00S004 | Flanders | 384 m² | 1 · 165 m² | 10.2 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
2 holdingsOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 2
-
50%
-
50%
According to the 2025 annual accounts of geroFarma and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Public money · subsidies and aid
Flemish government
2022 · 1 entry · 90 EUR awarded · 90 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 1 | 90 EUR | 90 EUR |
Similar companies · same sector, comparable size
APOTHEEK PANORAMA HOUTHALEN
BE 0780.806.943
Houthalen-Helchteren · Eq €240,577
PHARMACIE BOUCHAT
BE 0441.957.140
Gembloux · Eq €240,531
APOTHEEK VITAL
BE 0820.038.889
Middelkerke · Eq €240,380
PHARMACIE GRAAS
BE 0421.251.303
Liège · Eq €241,059
PharmaSil
BE 1007.715.677
Antwerpen · Eq €241,248
Of 5,220 companies in sector 47730 we hold annual accounts for 3,860. 3,540 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded02-10-2021
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID
0208:0774941908
Also
9925:BE0774941908
Registered
31-10-2023
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.